Introduction {#Sec1}
============

The recent global pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated coronavirus disease (COVID-19) \[[@CR1]\] has affected almost every country in the world \[[@CR2]\].

The World Health Organization is closely tracking the rapid spread of COVID-19 throughout the world, with daily situation reports \[[@CR3]\]. Table [1](#Tab1){ref-type="table"} shows a summary of the WHO's report of the total number of COVID-19 cases and the total number of COVID-19 deaths by region, taken from the last day of each month(March through July 2020). Increasingly, there is a recognition that COVID-19 is striking people living in poverty. This is happening on two fronts. Beginning with New Orleans in the spring of 2020, COVID-19 has caused significant devastation in low-income neighborhoods in US metro areas. African-American, Latino, and Native American populations living in these areas disproportionately account for the deaths and hospitalizations from COVID-19 \[[@CR9]\]. In addition, now, COVID-19 is affecting Latin American nations, especially in poor urban areas---the favelas---of Brazilian metro areas, and increasingly India and adjacent countries in South Asia, and Africa. COVID-19 has spread into these regions and populations aided by weakened health systems with inadequate public health interventions leading to an increase in numbers of cases. We are already starting to see significant levels of mortality in Brazilian cities, with the expectation that large metro areas and mega-cities in India and Africa will follow.Table 1A summary of the total numbers of cases and deaths in the different WHO regionsWHO regionsTotal cases (total deaths)March \[[@CR4]\]April \[[@CR5]\]May \[[@CR6]\]June \[[@CR7]\]July \[[@CR8]\]Africa3786 (77)24,713 (938)100,610 (2554)297,290 (6010)770,421 (13,234)Americas163,014 (2836)1,246,190 (65,228)2,743,793 (157,702)5,136,705 (247,129)9,152,173 (351,121)Eastern Mediterranean50,349 (2954)182,417 (7447)505,001 (12,353)1,058,055 (24,423)1,533,357 (39,661)Europe423,946 (26,694)1,434,649 (135,961)2,142,547 (180,085)2,692,086 (197,254)3,333,300 (212,520)South east Asia4215 (166)54,021 (2088)260,579 (7431)784,931 (21,593)2,009,963 (44,031)Western Pacific104,868 (3671)147,743 (6094)181,665 (7028)215,566 (7440)306,052 (8330)

Entering the Americas Southern Hemisphere {#Sec2}
=========================================

The initial entry of COVID-19 into the Southern Hemisphere is happening in Central and South America. Overwhelmingly, Brazil is the majorly affected country, especially in the favelas, the densely crowded slums of cities such as Sao Paulo, Rio de Janeiro, and Salvador de Bahia, but especially the northern tropical cities of Belem, Fortaleza, and Manaus. Urban areas of Chile, Peru, and Ecuador are also affected, and COVID-19 is expected to become one of the most widespread virus infections in Latin America (Table [2](#Tab2){ref-type="table"}). We also see significant levels of illness in Mesoamerica, referring to Mexico and Central America. Currently, Mexico has the highest case fatality rates in the Americas \[[@CR10]\]. The Caribbean is also beginning to see significant levels of infection with Trinidad and Tobago exceeded only by Mexico for case fatality rates, according to the Pan American Health Organization.Table 2A summary of the total numbers of cases, deaths, and recovered in the different subregions of the AmericasSub regionTotal cases (total deaths)\*Number of countriesCumulative casesCumulative deathsCumulative recoveredNorth America35,355,899216,0171,984,265Central America7212,5635924112,009South America104,445,110152,6873,057,235Caribbean34121,750197859,154\*<https://paho-covid19-response-who.hub.arcgis.com/> (accessed August 7, 2020)

For the past two decades, these countries within the Americas have confronted many health challenges mixed together with other political and socioeconomic hurdles \[[@CR11]\]. Beyond efforts to implement public health control, there are concerns that affected populations will experience long-term disabilities due to pulmonary scarring, cardiovascular complications, and neurologic deficits \[[@CR12]\], as well as other clinical manifestations still being discovered \[[@CR13]\]. Accordingly, these virus-related morbidities will add to the many already found in these populations already affected by non-communicable diseases functioning as major risk factors for COVID-19, as well as other infections, including the neglected tropical diseases (NTDs). A recent article in the *Public Library of Sciences Neglected Tropical Diseases* Journal provides a complete description and list of what are the NTDs predominantly all found in these regions \[[@CR14]\].

Now, COVID-19 is accelerating in India and elsewhere in South Asia. Estimates indicate that India could eventually exceed the USA or Brazil in terms of the total number of cases and deaths. There is an urgency to better understand the geographic distribution of India's COVID-19 epidemic, especially in terms of specifically affected urban areas. COVID-19 is also now affecting sub-Saharan Africa, beginning with South Africa and Egypt as the most affected countries. However, it is uncertain whether the relatively low number of cases across the region mostly reflects underreporting. For example, Tanzania has made claims to be unaffected by COVID-19 without external validation \[[@CR15]\].

The USA {#Sec3}
=======

Like many of the NTDs, COVID-19 has disproportionally targeted the most impoverished populations in high-income regions around the world \[[@CR2]\]. The concept of blue marble health refers to the "poorest of the rich" in nations such as the USA \[[@CR16]\]. A recent US study revealed that in the early stages of the pandemic, the populations living in the most underserved communities had higher rates of deaths due to COVID-19, compared with affluent locations \[[@CR17]\]. Initial thoughts hypothesized that these findings could be primarily due to a lack of access to testing in these communities. But it also gave clarity that these underserved communities found themselves at a serious disadvantage since the start of the pandemic. Social distancing is typically difficult in crowded households in low-income neighborhoods, where many do not have the opportunities to work from home. These poor populations generally have pre-existing health conditions due to inadequate access to high-quality healthcare. Among them are high rates of obesity, diabetes, and cardiovascular disease.

As is expected, of course, this also occurs in many areas around the world, especially in populations living in low- and middle-income countries (LMICs). In Brazil, for instance, a study evaluating the vulnerabilities and deprivations of their populations has identified several main factors contributing to this effect: hygiene, shelter, physical distance, and health recovery capacity \[[@CR18]\].

Poverty as the Common Denominator {#Sec4}
=================================

The basis by which poverty functions as a risk factor for COVID-19 requires further investigation. SARS-CoV-2 uses a respiratory route of infection, associated with droplet contact and possibly airborne transmission, and therefore, population density is known to have large adverse effects \[[@CR19]\]. It is very common that those who fall within low socioeconomic strata and/or live below the poverty level \[[@CR20]\] generally have several generations living under a single household. Therefore, living in close quarters with multiple inhabitants means direct contact with commonly used items; it can increase the risk of being exposed to the virus. In urban settings, additional factors that can lead to overcrowding may be the result of high rental costs, leading to families having to live in multi-family buildings and apartments \[[@CR21]\].

The economic downturn due to social distancing and decreased consumption of products and services has further disproportionally affected the poor. People living in poverty generally have less access to health communication on cable news networks or post-secondary education, working hourly positions that are more at the mercy of recessions. Since they do not maintain a standard salary, many people in poverty need to continue working hourly jobs and place themselves at risk from public exposure with COVID-19.

Other factors can influence COVID-19 morbidity and death, including age and non-communicable comorbidities such as diabetes, pulmonary, heart, or other organ-related diseases \[[@CR22], [@CR23]\]. This, in turn, can feedback and influence the high levels of transmission of SARS-CoV-2 seen in these populations contributing to the observed epidemiology of COVID-19 within these populations \[[@CR19]\]*.* Individuals with low socioeconomics also have higher comorbidities that come from poor nutrition and the lack of access to primary medical services. Health care is difficult to receive for people living below the poverty level. In both urban and rural settings, there is both a lack of accessible clinics for primary care and also a lack of insurance or the capacity to pay for preventive medical care. Higher rates of smoking and alcohol consumption are also prevalent in both urban and rural people living in poverty. Obesity, for instance, is associated with low-income populations, usually from consuming foods high in fats and carbohydrates that are still affordable. Diabetes is also a significant problem that can be related to obesity. Diabetes can severely impact the immune response of a person. All these health comorbidities can be the difference between asymptomatic COVID-19 infection and intubated in the intensive care unit.

COVID-19 and its Relationship with Tropical Diseases {#Sec5}
====================================================

There is increasing evidence that tropical diseases are also causative for propagating poverty in those infected \[[@CR24]\]. In the USA, an urban study in New York City reported a direct correlation with more *Toxocara* parasite in city parks from poor neighborhoods compared with rich boroughs \[[@CR25]\]. Another study in a clinic that serves low-income patients located in Washington D.C. was found to have endemic levels of a potentially dangerous parasite called *Strongyloides stercoralis* in this low-income population \[[@CR26]\]. A third study done in Chicago found evidence of both *Toxocara* and *Strongyloides* in this urban population \[[@CR27]\]. Major US cities had high levels of COVID-19 infections and a higher prevalence in those living below the poverty line \[[@CR28]\].

For rural areas in the USA, there are studies in Alabama that show hookworm (*Necator americanus*), and *Strongyloides stercoralis* is still present and transmitting in the population of poor rural Alabama \[[@CR24]\]. In Texas, a study detected 16.5% of people infected with *Strongyloides stercoralis* from a poor area outside of Austin, TX, that has limited sanitation facilities \[[@CR29]\]. COVID-19 has also been prevalent in the Southern USA \[[@CR21]\].

Linking COVID-19 to NTD Control {#Sec6}
===============================

Given the dire public health crisis created by the emergence of COVID-19, it is anticipated that global resources will be committed to disease control and prevention. As for funds for the COVID-19 vaccination scale, it will be interesting to look at opportunities to bundle these efforts for other tropical infections. For example, adult vaccinations for COVID-19 could be linked to scale-up for other adult vaccines, including influenza. As new vaccines for schistosomiasis and Chagas disease enter advanced development, there may be opportunities to link these as well \[[@CR30]\]. Outside of vaccines, we will need to look at bundling COVID-19 vaccines with mass treatments for malaria, tuberculosis, and HIV/AIDS, as well as large-scale programs for neglected tropical diseases. Until then, there are concerns that calls for social distancing might interrupt existing programs. There remains the possibility that we might see a resurgence in HIV/AIDS, tuberculosis, and malaria, and neglected tropical diseases. We have also seen how childhood vaccination programs for measles and other conditions were interrupted in the USA during the spring of 2020 \[[@CR31]\]. We may face similar interruptions in global child vaccination programs led by Gavi, the Vaccine Alliance.

Concluding Statement {#Sec7}
====================

The poor living in urban or rural areas of high-income countries and the most impoverished living in LMICs have increased risk for both COVID-19 and tropical diseases. These combinations disproportionally affect the working poor, both in health and economically, as to suffer long-term setbacks from missing work. The year 2020 is notable for the extraordinary global spread of COVID-19 and the interruptions in key public health programs for both neglected diseases and vaccine-preventable diseases. We face the potential for a slowing, halting, or even reversal of all of the amazing gains since the launch of the 2000 Millennium Development Goals. Given the anticipated support for COVID-19 vaccinations globally, it would seem wise to look at how some of the lapsed interventions could be resurrected and bundled.
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